In our latest video, Mr Mende tells us how autoantibody determination completely changed his prognosis. For the past six years, Mr Mende has suffered from necrotising myositis, an autoimmune disease that mainly affects the connective tissue and muscles. Today he is treated with immunosuppressants and is doing well, but receiving this diagnosis and successful therapy […]

Availability of EUROIMMUN products in the EU secured On May 10, 2023, EUROIMMUN received the certificate for its quality management system according to the new European Regulation on in vitro diagnostic medical devices (EU) 2017/746 (IVDR) from TÜV Rheinland LGA Products GmbH. On the one hand, the certificate enables EUROIMMUN to also convert products of

The UNIQO 160 embodies the next generation of fully automated systems for indirect immunofluorescence diagnostics. What is behind it? After the fully automated processing of the indirect immunofluorescence tests (IIFT), the system automatically covers the incubated slides with mounting medium to protect the slides from drying out. This alone is a special feature among fully

The cytoskeleton protein septin-3 has been identified as a novel target antigen of autoantibodies in patients with paraneoplastic cerebellar ataxia. The new biomarker was discovered in a collaborative study between scientists at EUROIMMUN, the University of Heidelberg and further clinics in Germany. Septins are cytoskeletal proteins with multiple roles in cell division, cellular polarisation, morphogenesis

Deep neural networks incorporating segmentation provide highly accurate classification of immunofluorescence patterns on the tissue substrates esophagus and salt-split skin for detection of autoimmune bullous dermatoses (AIBD). A recently published study in collaboration with researchers at the Department of Dermatology and Lübeck Institute of Experimental Dermatology of the University of Lübeck, Germany describes the development